Filing Details

Accession Number:
0001209191-11-022795
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-13 17:12:16
Reporting Period:
2011-04-11
Filing Date:
2011-04-13
Accepted Time:
2011-04-13 17:12:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478244 G Mark Currie C/O Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge MA 02142
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock Acquisiton 2011-04-11 600 $0.60 210,600 No 4 M Direct
Class B Common Stock Disposition 2011-04-11 600 $15.00 210,000 No 4 S Direct
Class B Common Stock Acquisiton 2011-04-13 24,263 $0.60 234,263 No 4 M Direct
Class B Common Stock Disposition 2011-04-13 24,263 $15.00 210,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Employee Stock Option (Right to Buy) Disposition 2011-04-11 600 $0.00 600 $0.60
Class B Common Stock Employee Stock Option (Right to Buy) Disposition 2011-04-13 24,263 $0.00 24,263 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,400 2012-09-24 No 4 M Direct
35,137 2012-09-24 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class B Common Stock Employee Stock Option (Right to Buy) $3.76 2018-01-31 120,000 120,000 Direct
Class B Common Stock Employee Stock Option (Right to Buy) $4.89 2019-02-11 125,000 125,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-01-31 120,000 120,000 Direct
2019-02-11 125,000 125,000 Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
  2. The option vested as to 25% of the shares of Class B Common Stock on the first anniversary of August 22, 2002, and 1/48th of the shares of Class B Common Stock vested each month thereafter for the next 36 months. The option was fully vested as of August 22, 2006.
  3. The expiration date of the option, as reported in the reporting person's Form 3 filed on February 2, 2010, contained a typographical error. The correct expiration date is January 31, 2018.
  4. The option vests as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2008 for the first 36 months, and vests as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option is subject to an early exercise provision and is immediately exercisable.
  5. The expiration date of the option, as reported in the reporting person's Form 3 filed on February 2, 2010, contained a typographical error. The correct expiration date is February 11, 2019.
  6. The option vests as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and vests as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option is subject to an early exercise provision and is immediately exercisable.